Non‐peptide agonists and positive allosteric modulators of glucagon‐like peptide‐1 receptors: Alternative approaches for treatment of Type 2 diabetes-Reference-Cited by-同舟云学术

Non‐peptide agonists and positive allosteric modulators of glucagon‐like peptide‐1 receptors: Alternative approaches for treatment of Type 2 diabetes

Published:2021-04-19 Issue:4 Volume:179 Page:511-525
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Malik Faisal¹,Li Zhijun¹

Affiliation:

1. Department of Chemistry and Biochemistry University of the Sciences in Philadelphia Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15446

Reference72 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

3. Aspnes G. E. Bagley S. W. Curto J. M. Dowling M. S. Edmonds D. J. Flanagan M. E. Futatsugi K. Griffith D. A. Huard K. Ingle G. Jiao W. Limberakis C. Mathiowetz A. M. Piotrowski D. W. &Ruggeri R. B.(2018).Glp‐1 receptor agonists and uses thereof. WO/2018/109607

4. Synthesis and Antidiabetic Activity of 3,6,7-Trisubstituted-2-(1H-imidazol-2-ylsulfanyl)quinoxalines and Quinoxalin-2-yl isothioureas

5. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological studies of 2-aminothiophene derivatives as positive allosteric modulators of glucagon-like peptide 1 receptor;Bioorganic & Medicinal Chemistry;2024-09

2. Binding sites and design strategies for small molecule GLP-1R agonists;European Journal of Medicinal Chemistry;2024-09

3. The role of incretin receptor agonists in the treatment of obesity;Diabetes, Obesity and Metabolism;2024-07-29

4. Towards the recognition of oligogenic forms of type 2 diabetes;Trends in Endocrinology & Metabolism;2024-07

5. A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency;Bioorganic & Medicinal Chemistry;2024-06